Presymptomatic Profiles of Cognitive Impairment with Prior Mobility Impairment

J Am Med Dir Assoc. 2024 Mar;25(3):480-487.e2. doi: 10.1016/j.jamda.2023.12.017. Epub 2024 Jan 30.

Abstract

Objectives: To identify cognitive and health profiles of cognitively impaired older adults with the presence of prior mobility impairment, which may represent a specific pathway to the development of cognitive impairment or dementia.

Design: Retrospective longitudinal study.

Setting and participants: In adults aged ≥65 years who developed cognitive impairment or dementia, we compared cognitive and health profiles of those who did (n = 57) and did not (n = 86) experience slow gait up to 14 years before symptom onset. Measures of cognitive and biomarkers assessed longitudinally over an average of 7 years before symptom onset were compared between groups using linear mixed effects models, adjusted age, sex, race, and additionally adjusted for education for cognitive outcomes.

Results: Compared to those without prior slow gait, those with slow gait had lower Digit Symbol Substitution Test and Pegboard dominant and nondominant hand performance. The slow gait group also had greater body mass index (BMI), waist, systolic blood pressure, lower high-density lipoprotein and low-density lipoprotein, and lower lysophosphatidylcholine 18:2, a lipid associated with mitochondrial function, and showed greater increases in 2-hour glucose levels of an oral glucose tolerance test. The slow gait group was more likely to take medication for hypertension and hypercholesterolemia.

Conclusions and implications: During the presymptomatic stage, cognitively impaired older persons who experience prior slow gait are more likely to have deficits in psychomotor speed and manual dexterity, an unfavorable metabolic and vascular profile, and lower lipid levels related to mitochondrial function. Older persons who exhibit mobility impairment should be evaluated for metabolic and vascular dysfunction at an early stage, and successful treatment of these conditions may slow down the progression of cognitive impairment or dementia.

Keywords: Cognitive impairment; metabolic disorder; mobility impairment; presymptomatic; psychomotor speed; vascular burden.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cognitive Dysfunction*
  • Dementia*
  • Humans
  • Lipids
  • Longitudinal Studies
  • Retrospective Studies

Substances

  • Lipids